UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Xylocain-Dental-Adrenalin-SE-AJ-MPD-BBDL

Xylocain Dental Adrenalin 20 mg/ml + 12,5 mikrogram/ml Injektionsvätska, lösning

MPID: SE-100003299-00003844
EURDID: 1233

Full name: Xylocain Dental Adrenalin 20 mg/ml + 12,5 mikrogram/ml Injektionsvätska, lösning

- Invented Name Part: Xylocain

- Intended use part: Dental

- Scientific Name Part: Adrenalin

- Strength part: 20 mg/ml + 12,5 mikrogram/ml

- Pharmaceutical dose form part: Injektionsvätska, lösning

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Solution for injection

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097207 lidocaine, combinations

Marketing Authorisation 1 of 1

Authorisation number: 3844

Region: Kingdom of Sweden

Marketing authorisation holder: Dentsply DeTrey GmbH

Identifier:

  • LOC-100007631

Status: Valid (1951-05-31)

Package 1 of 2

PCID:

Description:
Cylinderampull (självaspirerande), 100 x 1,8 ml

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 cartridge

Package: 1 Box (Cardboard)

Containing:

Package: 100 Cartridge (Glass)

Containing: 1.8 millilitre(s)

Manufactured Item

Dose form: Solution for injection

Unit of presentation: Cartridge

Ingredient

Role: Active

Substance: Lidocaine hydrochloride monohydrate

Concentration strength: 21.33 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine hydrochloride 20 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine 17.3 milligram(s) / 1 millilitre(s)

Ingredient

Role: Active

Substance: Adrenaline tartrate

Concentration strength: 22.7 microgram(s) / 1 millilitre(s)

Reference strength:
Adrenaline 12.5 microgram(s) / 1 millilitre(s)

Package 2 of 2

PCID:

Description:
Cylinderampull (självaspirerande), 100 x 1,8 ml

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 cartridge

Package: 1 Box (Cardboard)

Containing:

Package: 100 Cartridge (Glass)

Containing: 1.8 millilitre(s)

Manufactured Item

Dose form: Solution for injection

Unit of presentation: Cartridge

Ingredient

Role: Active

Substance: Lidocaine hydrochloride monohydrate

Concentration strength: 21.33 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine hydrochloride 20 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine 17.3 milligram(s) / 1 millilitre(s)

Ingredient

Role: Active

Substance: Adrenaline tartrate

Concentration strength: 22.7 microgram(s) / 1 millilitre(s)

Reference strength:
Adrenaline 12.5 microgram(s) / 1 millilitre(s)

Administrable Product (1 of 1)

Dose form: Solution for injection

Unit of presentation:

Route of administration:

  • Perineural use
  • Infiltration

Ingredients:

Ingredient

Role: Active

Substance: Lidocaine hydrochloride monohydrate

Concentration strength: 21.33 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine hydrochloride 20 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine 17.3 milligram(s) / 1 millilitre(s)

Ingredient

Role: Active

Substance: Adrenaline tartrate

Concentration strength: 22.7 microgram(s) / 1 millilitre(s)

Reference strength:
Adrenaline 12.5 microgram(s) / 1 millilitre(s)